ANCA-positive vasculitis associated with allopurinol therapy

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 743-744

  Choil, H K ^a,b   Merkep, P A ^a,b   Niles, J L ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allopurinol; Anti neutrophil cytoplasmic antibodies; Myeloperoxidase; Vasculitis

Indexed keywords

ALLOPURINOL; MYELOBLASTIN; MYELOPEROXIDASE; NAPROXEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLIN G;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME SPECIFICITY; ERYTHROCYTE SEDIMENTATION RATE; GOUT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; VASCULITIS;

ALLOPURINOL; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; GOUT SUPPRESSANTS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PEROXIDASE; VASCULITIS;

EID: 0031763635     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. MILES JL: Antineutrophil cytoplasmic antibodies in the classification of vasculitis. Anna Rev Med 1996; 47:303-13.
2. GROSS WL: Antineutrophil cytoplasmic autoantibody testing in vasculitides. Rheum Dis Clin North Am 1995; 21:987-1011.
3. FALK RJ, JENNETTE JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 1997; 8:314-22.
4. MERKEL PA: Drugs associated with vasculitis. Curr Opin Rheumatol 1998; 10: 45-50.
5. NASSBERGER L, JOHANSSON AC, BJORCK S, SJOHOLM AG: Antibodies to neutrophil granulocyte myeloperoxidase and elastase: Autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med 1991; 229: 261-5.
6. CAMBRIDGE G, WALLACE H, BERNSTEIN RM, LEAKER B: Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33:109-14.
7. SHORT AK, LOCKWOOD CM: Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM 1995; 88: 77583.
8. DOLMAN KM, GANS RO, VERVAAT TJ, et al: Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.
9. VOGT BA, KIM Y, JENNETTE JC, FALK RJ, BURKE BA, SINAIKO A: Antineutrophil cytoplasmic autoantibody-positive crescentic glomerulonephritis as a complication of treatment with propylthiouracil in children. J Pedialr 1994; 124: 986-8.
10. D'CRUZ D, CHESSER AM, LIGHTOWLER C, et al.: Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment. BrJ Rheumatol 1995; 34:1090-1.
11. MERKEL PA, POLISSON RP.CHANGY, SKATES SJ, NILES JL: Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126: 866-73.
12. JAUNKALNS R, SHEAR NH, SOKOLUK B, GARDNER D, CLAAS F, UETRECHT JP: Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet 1992;339:1611-2.
13. ARELLANO F, SACRISTAN JA: Allopurinol hypersensitivity syndrome: A review. Ann Pharmacother 1993; 27: 337-43.
14. ROTHWELL PM, GRANT R: Cerebral vasculitis following allopurinol treatment. Postgrad MedJ 1996; 72:119-20.